Are orthopedic clinical trials representative? An analysis of race and ethnicity reported in clinical trials between 2007 and 2022 : Running title: representation of clinical trials in orthopedic surgery
- PMID: 38554209
- DOI: 10.1007/s00402-024-05285-7
Are orthopedic clinical trials representative? An analysis of race and ethnicity reported in clinical trials between 2007 and 2022 : Running title: representation of clinical trials in orthopedic surgery
Abstract
Introduction: Prior studies investigating the racial and ethnic representation of orthopedic trial participants have found low rates of reporting, but these studies are dated due to the passing of the National Institutes of Health Final Rule in 2017 requiring the reporting of racial and ethnic data among clinical trials. Therefore, we evaluated the representativeness of orthopedic clinical trials before and after the Final Rule.
Methods: A cross-sectional survey of orthopaedic clinical trials registered at ClinicalTrials.gov between October 1, 2007 and May 20, 2023 was conducted. After identifying and screening 23,752 clinical trials, 1564 trials were included in the analysis. Trials started before the implementation of the Final Rule on January 18, 2017 were grouped and compared to trials that began after. Odds ratios (OR) were utilized to identify trial characteristics associated with reporting race/ethnicity data. One-proportion z tests compared the representation of each racial and ethnic category to the 2020 United States Census.
Results: In total, 34% (544 of 1564) of orthopedic clinical trials evaluated reported the race of participants, while 28% (438 of 1564) reported ethnicity. Trials registered after the Final Rule were more likely to report racial (OR: 5.15, 95%CI: 3.72-7.13, p < 0.001) and ethnic (OR: 3.23, 95%CI: 2.41-4.33, p < 0.001) representation of participants. Compared with the distribution of race and ethnicity reported by the United States 2020 Census, orthopedic trials had 16.6% more White participants (95% CI 16.4%, 16.8%; p < 0.001), 3.2% fewer Black participants (95%CI 3.1%, 3.3%; p < 0.001), and 5.7% fewer Hispanic/Latino participants (95%CI 5.2%, 6.2%; p < 0.001). Trials with enrollment sizes over 100 participants were also more likely to report race and ethnicity, with odds increasing with increased sample size.
Conclusions: The Final Rule marginally improved the reporting of race and ethnicity in orthopedic clinical trials, and underrepresentation of Black or African American, Multiracial, and Hispanic populations persists.
Level of evidence: III.
Keywords: Clinical trials; Disparities; Ethnicity; Orthopedic surgery; Race.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Is Our Science Representative? A Systematic Review of Racial and Ethnic Diversity in Orthopaedic Clinical Trials from 2000 to 2020.Clin Orthop Relat Res. 2022 May 1;480(5):848-858. doi: 10.1097/CORR.0000000000002050. Epub 2021 Dec 2. Clin Orthop Relat Res. 2022. PMID: 34855650 Free PMC article.
-
Disparities in Race and Ethnicity Reporting and Representation for Clinical Trials in Stroke: 2010 to 2020.J Am Heart Assoc. 2024 Mar 19;13(6):e033467. doi: 10.1161/JAHA.123.033467. Epub 2024 Mar 8. J Am Heart Assoc. 2024. PMID: 38456461 Free PMC article.
-
Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials.JAMA Netw Open. 2021 Feb 1;4(2):e2037640. doi: 10.1001/jamanetworkopen.2020.37640. JAMA Netw Open. 2021. PMID: 33606033 Free PMC article. Review.
-
Reporting of Participant Race and Ethnicity in Published US Pediatric Clinical Trials From 2011 to 2020.JAMA Pediatr. 2022 May 1;176(5):e220142. doi: 10.1001/jamapediatrics.2022.0142. Epub 2022 May 2. JAMA Pediatr. 2022. PMID: 35311946 Free PMC article.
-
Race and ethnicity reporting and representation in hemophilia clinical trials.Blood Adv. 2024 May 28;8(10):2351-2360. doi: 10.1182/bloodadvances.2024012862. Blood Adv. 2024. PMID: 38547444 Free PMC article.
References
-
- Pandya NK, Wustrack R, Metz L, Ward D (2018) Current concepts in orthopaedic care disparities. J Am Acad Orthop Surg 26:823–832. https://doi.org/10.5435/JAAOS-D-17-00410 - DOI - PubMed
-
- Zavala VA, Bracci PM, Carethers JM et al (2021) Cancer health disparities in racial/ethnic minorities in the United States. Br J Cancer 124:315. https://doi.org/10.1038/S41416-020-01038-6 - DOI - PubMed
-
- Trinh MH, Agénor M, Austin SB, Jackson CL (2017) Health and healthcare disparities among U.S. women and men at the intersection of sexual orientation and race/ethnicity: a nationally representative cross-sectional study. BMC Public Health 17:964. https://doi.org/10.1186/S12889-017-4937-9 - DOI - PubMed - PMC
-
- Zimmerman FJ, Anderson NW (2019) Trends in Health Equity in the United States by Race/Ethnicity, Sex, and Income, 1993–2017. JAMA Netw Open 2:. https://doi.org/10.1001/JAMANETWORKOPEN.2019.6386
-
- 110th United States Congress (2007) Food and Drug Administration Amendments Act (FDAAA) of 2007. In: US Food and Drug Administration. https://www.govinfo.gov/content/pkg/PLAW-110publ85/pdf/PLAW-110publ85.pdf . Accessed 29 Aug 2023
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials